NCT00696995View on ClinicalTrials.gov

An Observational Study of Type 2 Diabetes in Patients Starting on NovoMix® 30 Treatment

CompletedOBSERVATIONAL
Enrollment

509

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
DRUG

biphasic insulin aspart 30

Start dose and frequency as well as dose alterations to be determined by the physician according to normal clinical evaluation

Trial Locations (1)

15110

Novo Nordisk Investigational Site, Lahti

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT00696995 - An Observational Study of Type 2 Diabetes in Patients Starting on NovoMix® 30 Treatment | Biotech Hunter | Biotech Hunter